{
    "id": "dbpedia_6595_2",
    "rank": 44,
    "data": {
        "url": "https://www.urmc.rochester.edu/people/112358768-robert-g-holloway",
        "read_more_link": "",
        "language": "en",
        "title": "Robert G. Holloway, M.D., M.P.H.",
        "top_image": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3966.jpg",
        "meta_img": "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3966.jpg",
        "images": [
            "https://www.urmc.rochester.edu/getmedia/2d3c0d22-0eae-4ef9-b5cd-2051e0747bd8/UR-Medicine-logo-svg.svg?maxsidesize=400&resizemode=force",
            "https://www.urmc.rochester.edu/ecv_binary/faculty/generated/profile_web/3966.jpg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The University of Rochester Medical Center (URMC) is one of the nation’s leading academic medical centers. It forms the centerpiece of the University of Rochester’s health research, teaching and patient care missions.\r\n\r\nThe University of Rochester Medical Center is a private, coeducational, nonsectarian, and nonprofit research university.",
        "meta_lang": "en",
        "meta_favicon": "",
        "meta_site_name": "University of Rochester Medical Center",
        "canonical_link": "https://www.urmc.rochester.edu/people/112358768-robert-g-holloway",
        "text": "Impact of the COVID-19 Pandemic on Inpatient Utilization for Acute Neurologic Disease.\n\nYoo A, Guterman EL, Hwang DY, Holloway RG, George BP\n\nThe Neurohospitalist.. 2024 January 14 (1):13-22. Epub 08/17/2023.\n\nNeuropalliative Care for Stroke Providers.\n\nCreutzfeldt CJ, Abedini NC, Holloway RG\n\nStroke.. 2023 November 54 (11):e485-e487. Epub 10/10/2023.\n\nNational Cost Estimates of Invasive Mechanical Ventilation and Tracheostomy in Acute Stroke, 2008-2017.\n\nAlbert GP, McHugh DC, Hwang DY, Creutzfeldt CJ, Holloway RG, George BP\n\nStroke.. 2023 October 54 (10):2602-2612. Epub 09/14/2023.\n\nHospital Discharge and Readmissions Before and During the COVID-19 Pandemic for California Acute Stroke Inpatients.\n\nAlbert GP, McHugh DC, Roberts DE, Kelly AG, Okwechime R, Holloway RG, George BP\n\nJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2023 August 32 (8):107233. Epub 06/23/2023.\n\nGlobal neurology: It's time to take notice.\n\nRutkove SB, Poduri A, Holloway RG, Pomeroy SL, McArthur JC\n\nAnnals of clinical and translational neurology.. 2023 May 10 (5):842-845. Epub 03/23/2023.\n\nIdentification of Palliative Care Needs and Mental Health Outcomes Among Family Members of Patients With Severe Acute Brain Injury.\n\nPlinke WV, Buchbinder SA, Brumback LC, Longstreth WT, Kiker WA, Holloway RG, Engelberg RA, Curtis JR, Creutzfeldt CJ\n\nJAMA network open.. 2023 April 36 (4):e239949. Epub 04/03/2023.\n\nSkilled Nursing Facility Participation in Bundled Payments Was Related to Small Increases in Nurse Staffing Levels.\n\nYing M, Temkin-Greener H, Thirukumaran CP, Joynt Maddox KE, Holloway RG, Li Y\n\nJournal of applied gerontology : the official journal of the Southern Gerontological Society.. 2023 March 42 (3):456-463. Epub 11/02/2022.\n\nAssociation of Skilled Nursing Facility Participation in Voluntary Bundled Payments With Postacute Care Outcomes for Joint Replacement.\n\nYing M, Thirukumaran CP, Temkin-Greener H, Joynt Maddox KE, Holloway RG, Li Y\n\nMedical care.. 2023 February 161 (2):109-116. Epub 12/12/2022.\n\nEmerging Subspecialties in Neurology: Cortical Careers in Neuropalliative Care.\n\nNg M, McFarlin J, Holloway RG, Miyasaki J, Kramer NM\n\nNeurology.. 2023 January 17100 (3):158-161. Epub 10/20/2022.\n\nAdvancing the Neuropalliative Care Approach-A Call to Action.\n\nHolloway RG, Kramer NM\n\nJAMA neurology.. 2023 January 180 (1):7-8. Epub 1900 01 01.\n\nEffect of COVID-19 pandemic on outcomes in intracerebral hemorrhage.\n\nMcHugh DC, Gershteyn A, Boerman C, Holloway RG, Roberts DE, George BP\n\nPloS one.. 2023 18 (4):e0284845. Epub 04/26/2023.\n\nA Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson Disease: Baseline Results.\n\nJensen-Roberts S, Myers TL, Auinger P, Cannon P, Rowbotham HM, Coker D, Chanoff E, Soto J, Pawlik M, Amodeo K, Sharma S, Valdovinos B, Wilson R, Sarkar A, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Holloway RG, Dorsey ER, Schneider RB\n\nNeurology. Genetics.. 2022 October 8 (5):e200008. Epub 08/11/2022.\n\nReversal of Advanced Directives in Neurologic Emergencies.\n\nMcHugh DC, George BP, Bender MT, Horowitz RK, Kaufman DC, Holloway RG, Roberts DE\n\nThe Neurohospitalist.. 2022 October 12 (4):651-658. Epub 06/15/2022.\n\nAssociation of Time Elapsed Since Ischemic Stroke With Risk of Recurrent Stroke in Older Patients Undergoing Elective Nonneurologic, Noncardiac Surgery.\n\nGlance LG, Benesch CG, Holloway RG, Thirukumaran CP, Nadler JW, Eaton MP, Fleming FJ, Dick AW\n\nJAMA surgery.. 2022 August 1157 (8):e222236. Epub 08/10/2022.\n\nA Multi-Component Transition of Care Improvement Project to Reduce Hospital Readmissions Following Ischemic Stroke.\n\nLeonhardt-Caprio AM, Sellers CR, Palermo E, Caprio TV, Holloway RG\n\nThe Neurohospitalist.. 2022 April 12 (2):205-212. Epub 08/05/2021.\n\nDevelopment and Dissemination of a Neurology Palliative Care Curriculum: Education in Palliative and End-of-Life Care Neurology.\n\nKluger BM, Kramer NM, Katz M, Galifianakis NB, Pantilat S, Long J, Vaughan CL, Foster LA, Creutzfeldt CJ, Holloway RG, Sillau S, Hauser J\n\nNeurology. Clinical practice.. 2022 April 12 (2):176-182. Epub 1900 01 01.\n\nAssociation of Medicare Mandatory Bundled Payment Reform With Joint Replacement Surgery Use for Beneficiaries With Alzheimer Disease and Related Dementias.\n\nThirukumaran CP, Ricciardi BF, Cai X, Holloway RG, Li Y, Glance LG\n\nJAMA health forum.. 2022 February 3 (2):e215111. Epub 02/11/2022.\n\nSkilled Nursing Facility Participation in a Voluntary Medicare Bundled Payment Program: Association With Facility Financial Performance.\n\nYing M, Temkin-Greener H, Thirukumaran CP, Joynt Maddox KE, Holloway RG, Li Y\n\nMedical care.. 2022 January 160 (1):83-92. Epub 1900 01 01.\n\nRecruitment for Remote Decentralized Studies in Parkinson's Disease.\n\nMyers TL, Augustine EF, Baloga E, Daeschler M, Cannon P, Rowbotham H, Chanoff E, , Jensen-Roberts S, Soto J, Holloway RG, Marras C, Tanner CM, Ray Dorsey E, Schneider RB\n\nJournal of Parkinson's disease.. 2022 12 (1):371-380. Epub 1900 01 01.\n\nPrognostication in neurology.\n\nRisco JR, Kelly AG, Holloway RG\n\nHandbook of clinical neurology.. 2022 190 :175-193. Epub 1900 01 01.\n\nAssessment of Discordance Between Physicians and Family Members Regarding Prognosis in Patients With Severe Acute Brain Injury.\n\nKiker WA, Rutz Voumard R, Andrews LIB, Holloway RG, Brumback LC, Engelberg RA, Curtis JR, Creutzfeldt CJ\n\nJAMA network open.. 2021 October 14 (10):e2128991. Epub 10/01/2021.\n\nPredictors of Surrogate Decision Makers Selecting Life-Sustaining Therapy for Severe Acute Brain Injury Patients: An Analysis of US Population Survey Data.\n\nGarg A, Soto AL, Knies AK, Kolenikov S, Schalk M, Hammer H, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY\n\nNeurocritical care.. 2021 October 35 (2):468-479. Epub 02/23/2021.\n\nPerioperative Neurological Evaluation and Management to Lower the Risk of Acute Stroke in Patients Undergoing Noncardiac, Nonneurological Surgery: A Scientific Statement From the American Heart Association/American Stroke Association.\n\nBenesch C, Glance LG, Derdeyn CP, Fleisher LA, Holloway RG, Messé SR, Mijalski C, Nelson MT, Power M, Welch BG,\n\nCirculation.. 2021 May 11143 (19):e923-e946. Epub 04/08/2021.\n\nJoy, Suffering, and the Goals of Medicine.\n\nKluger BM, Garvan CW, Holloway RG\n\nJAMA neurology.. 2021 March 178 (3):265-266. Epub 1900 01 01.\n\nProceedings from the Neurotherapeutics Symposium on Neurological Emergencies: Shaping the Future of Neurocritical Care.\n\nSimpkins AN, Busl KM, Amorim E, Barnett-Tapia C, Cervenka MC, Dhakar MB, Etherton MR, Fung C, Griggs R, Holloway RG, Kelly AG, Khan IR, Lizarraga KJ, Madagan HG, Onweni CL, Mestre H, Rabinstein AA, Rubinos C, Dionisio-Santos DA, Youn TS, Merck LH, Maciel CB,\n\nNeurocritical care.. 2020 December 33 (3):636-645. Epub 09/21/2020.\n\nNeuropalliative care essentials for the COVID-19 crisis.\n\nKluger BM, Vaughan CL, Robinson MT, Creutzfeldt C, Subramanian I, Holloway RG\n\nNeurology.. 2020 September 195 (9):394-398. Epub 06/26/2020.\n\nMedicare Shared Savings Program and readmission rate among patients with ischemic stroke.\n\nKim Y, Glance LG, Holloway RG, Li Y\n\nNeurology.. 2020 August 2595 (8):e1071-e1079. Epub 06/17/2020.\n\nDelirium disorder: Integrating delirium and acute encephalopathy.\n\nOldham MA, Holloway RG\n\nNeurology.. 2020 July 2895 (4):173-178. Epub 06/09/2020.\n\nSeven-Year Experience From the National Institute of Neurological Disorders and Stroke-Supported Network for Excellence in Neuroscience Clinical Trials.\n\nCudkowicz M, Chase MK, Coffey CS, Ecklund DJ, Thornell BJ, Lungu C, Mahoney K, Gutmann L, Shefner JM, Staley KJ, Bosch M, Foster E, Long JD, Bayman EO, Torner J, Yankey J, Peters R, Huff T, Conwit RA, , Shinnar S, Patch D, Darras BT, Ellis A, Packer RJ, Marder KS, Chiriboga CA, Henchcliffe C, Moran JA, Nikolov B, Factor SA, Seeley C, Greenberg SM, Amato AA, DeGregorio S, Simuni T, Ward T, Kissel JT, Kolb SJ, Bartlett A, Quinn JF, Keith K, Levine SR, Gilles N, Coyle PK, Lamb J, Wolfe GI, Crumlish A, Mejico L, Iqbal MM, Bowen JD, Tongco C, Nabors LB, Bashir K, Benge M, McDonald CM, Henricson EK, Oskarsson B, Dobkin BH, Canamar C, Glauser TA, Woo D, Molloy A, Clark P, Vollmer TL, Stein AJ, Barohn RJ, Dimachkie MM, Le Pichon JB, Benatar MG, Steele J, Wechsler L, Clemens PR, Amity C, Holloway RG, Annis C, Goldberg MP, Andersen M, Iannaccone ST, Smith AG, Singleton JR, Doudova M, Haley EC, Quigg MS, Lowenhaupt S, Malow BA, Adkins K, Clifford DB, Teshome MA, Connolly N\n\nJAMA neurology.. 2020 June 177 (6):755-763. Epub 1900 01 01.\n\nBalancing Past vs Future Values in Decision-Making-Reply.\n\nCreutzfeldt CJ, Holloway RG\n\nJAMA.. 2020 May 19323 (19):1976. Epub 1900 01 01.\n\nConcerns of surrogate decision makers for patients with acute brain injury: A US population survey.\n\nHwang DY, Knies AK, Mampre D, Kolenikov S, Schalk M, Hammer H, White DB, Holloway RG, Sheth KN, Fraenkel L\n\nNeurology.. 2020 May 1294 (19):e2054-e2068. Epub 04/27/2020.\n\nPalliative care and Parkinson's disease: outpatient needs and models of care over the disease trajectory.\n\nTarolli CG, Holloway RG\n\nAnnals of palliative medicine.. 2020 February 9 (Suppl 1):S44-S51. Epub 12/13/2019.\n\nSymptom burden among individuals with Parkinson disease: A national survey.\n\nTarolli CG, Zimmerman GA, Auinger P, McIntosh S, Horowitz RK, Kluger BM, Dorsey ER, Holloway RG\n\nNeurology. Clinical practice.. 2020 February 10 (1):65-72. Epub 11/18/2019.\n\nTreatment Decisions for a Future Self: Ethical Obligations to Guide Truly Informed Choices.\n\nCreutzfeldt CJ, Holloway RG\n\nJAMA.. 2020 January 14323 (2):115-116. Epub 1900 01 01.\n\nA Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design.\n\nSchneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, , Holloway RG, Dorsey ER\n\nJournal of Parkinson's disease.. 2020 10 (3):1195-1207. Epub 1900 01 01.\n\nCommon Data Elements for Unruptured Intracranial Aneurysms and Aneurysmal Subarachnoid Hemorrhage: Recommendations from the Working Group on Hospital Course and Acute Therapies-Proposal of a Multidisciplinary Research Group.\n\nde Oliveira Manoel AL, van der Jagt M, Amin-Hanjani S, Bambakidis NC, Brophy GM, Bulsara K, Claassen J, Connolly ES, Hoffer SA, Hoh BL, Holloway RG, Kelly AG, Mayer SA, Nakaji P, Rabinstein AA, Vajkoczy P, Vergouwen MDI, Woo H, Zipfel GJ, Suarez JI,\n\nNeurocritical care.. 2019 June 30 (Suppl 1):36-45. Epub 1900 01 01.\n\nIncidental Findings in Radiographic Imaging for Inpatients with Acute Ischemic Stroke.\n\nDoyle SJ, George BP, Holloway RG, Kelly AG\n\nJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2018 November 27 (11):3131-3136. Epub 08/02/2018.\n\nPost-acute care discharge delays for neurology inpatients: Opportunity to improve patient flow.\n\nRoberts DE, Holloway RG, George BP\n\nNeurology. Clinical practice.. 2018 August 8 (4):302-310. Epub 1900 01 01.\n\nNeuropalliative care: Priorities to move the field forward.\n\nCreutzfeldt CJ, Kluger B, Kelly AG, Lemmon M, Hwang DY, Galifianakis NB, Carver A, Katz M, Curtis JR, Holloway RG\n\nNeurology.. 2018 July 3191 (5):217-226. Epub 06/27/2018.\n\nGuideline: The AHA/ASA made 217 recommendations for early management of acute ischemic stroke in adults.\n\nKelly AG, Holloway RG\n\nAnnals of internal medicine.. 2018 June 19168 (12):JC63. Epub 1900 01 01.\n\nInterfacility transfers for US ischemic stroke and TIA, 2006-2014.\n\nGeorge BP, Doyle SJ, Albert GP, Busza A, Holloway RG, Sheth KN, Kelly AG\n\nNeurology.. 2018 May 190 (18):e1561-e1569. Epub 04/04/2018.\n\nVariability in Gastrostomy Tube Placement for Intracerebral Hemorrhage Patients at US Hospitals.\n\nHwang DY, George BP, Kelly AG, Schneider EB, Sheth KN, Holloway RG\n\nJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2018 April 27 (4):978-987. Epub 12/06/2017.\n\nFor-Profit Hospital Status and Carotid Artery Stent Utilization in US Hospitals Performing Carotid Revascularization.\n\nChandler JV, George BP, Kelly AG, Holloway RG\n\nStroke.. 2017 November 48 (11):3161-3164. Epub 09/22/2017.\n\nPalliative Care in Neurology.\n\nRobinson MT, Holloway RG\n\nMayo Clinic proceedings.. 2017 October 92 (10):1592-1601. Epub 1900 01 01.\n\nPalliative and end-of-life care in glioblastoma: defining and measuring opportunities to improve care.\n\nHemminger LE, Pittman CA, Korones DN, Serventi JN, Ladwig S, Holloway RG, Mohile NA\n\nNeuro-oncology practice.. 2017 September 4 (3):182-188. Epub 09/27/2016.\n\nRaising the Alarm on Brain Attacks in Surgical Patients: Are We Doing Enough to Prevent and Treat Postoperative Strokes?\n\nGlance LG, Holloway RG\n\nAnesthesiology.. 2017 July 127 (1):3-5. Epub 1900 01 01.\n\nThe emerging partnership between palliative care and stroke.\n\nHolloway RG, Bernat JL\n\nNeurology. Clinical practice.. 2017 June 7 (3):191-193. Epub 1900 01 01.\n\nJunior faculty core curriculum to enhance faculty development.\n\nGuillet R, Holloway RG, Gross RA, Libby K, Shapiro JR\n\nJournal of clinical and translational science.. 2017 April 1 (2):77-82. Epub 02/27/2017.\n\nTiming of Percutaneous Endoscopic Gastrostomy for Acute Ischemic Stroke: An Observational Study From the US Nationwide Inpatient Sample.\n\nGeorge BP, Kelly AG, Albert GP, Hwang DY, Holloway RG\n\nStroke.. 2017 February 48 (2):420-427. Epub 12/13/2016.\n\nIncreasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.\n\nBerk S, Greco BL, Biglan K, Kopil CM, Holloway RG, Meunier C, Simuni T\n\nJournal of Parkinson's disease.. 2017 7 (4):685-693. Epub 1900 01 01.\n\nAre patients with amyotrophic lateral sclerosis at risk of a therapeutic misconception?\n\nKim SY, Wilson R, De Vries R, Ryan KA, Holloway RG, Kieburtz K\n\nJournal of medical ethics.. 2016 August 42 (8):514-8. Epub 03/10/2016.\n\nUnderstanding the 'therapeutic misconception' from the research participant's perspective.\n\nKim SY, De Vries R, Holloway RG, Kieburtz K\n\nJournal of medical ethics.. 2016 August 42 (8):522-3. Epub 05/04/2016.\n\nThe lack of documentation of preferences in a cohort of adults who died after ischemic stroke.\n\nRobinson MT, Vickrey BG, Holloway RG, Chong K, Williams LS, Brook RH, Leng M, Parikh P, Zingmond DS\n\nNeurology.. 2016 May 3186 (22):2056-62. Epub 04/08/2016.\n\nNeurologists as primary palliative care providers: Communication and practice approaches.\n\nCreutzfeldt CJ, Robinson MT, Holloway RG\n\nNeurology. Clinical practice.. 2016 February 6 (1):40-48. Epub 1900 01 01.\n\nPalliative Care: A Core Competency for Stroke Neurologists.\n\nCreutzfeldt CJ, Holloway RG, Curtis JR\n\nStroke.. 2015 September 46 (9):2714-9. Epub 08/04/2015.\n\nPredicting decline and survival in severe acute brain injury: the fourth trajectory.\n\nCreutzfeldt CJ, Longstreth WT, Holloway RG\n\nBMJ : British medical journal. 2015 August 6351 :h3904. Epub 08/06/2015.\n\nPalliative Care Needs in the Neuro-ICU.\n\nCreutzfeldt CJ, Engelberg RA, Healey L, Cheever CS, Becker KJ, Holloway RG, Curtis JR\n\nCritical care medicine.. 2015 August 43 (8):1677-84. Epub 1900 01 01.\n\n&quot;It is not guaranteed that you will benefit&quot;: True but misleading?\n\nKim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K\n\nClinical trials : journal of the Society for Clinical Trials.. 2015 August 12 (4):424-9. Epub 05/11/2015.\n\nPatient Preferences and Surrogate Decision Making in Neuroscience Intensive Care Units.\n\nCai X, Robinson J, Muehlschlegel S, White DB, Holloway RG, Sheth KN, Fraenkel L, Hwang DY\n\nNeurocritical care.. 2015 August 23 (1):131-41. Epub 1900 01 01.\n\nAre therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?\n\nKim SY, De Vries R, Parnami S, Wilson R, Kim HM, Frank S, Holloway RG, Kieburtz K\n\nJournal of medical ethics.. 2015 May 41 (5):391-7. Epub 05/22/2014.\n\nCould the High Prevalence of Therapeutic Misconception Partly Be a Measurement Problem?\n\nKim SY, Wilson R, De Vries R, Kim HM, Holloway RG, Kieburtz K\n\nIRB.. 2015 37 (4):11-8. Epub 1900 01 01.\n\nRacial/Ethnic differences in process of care and outcomes among patients hospitalized with intracerebral hemorrhage.\n\nXian Y, Holloway RG, Smith EE, Schwamm LH, Reeves MJ, Bhatt DL, Schulte PJ, Cox M, Olson DM, Hernandez AF, Lytle BL, Anstrom KJ, Fonarow GC, Peterson ED\n\nStroke.. 2014 November 45 (11):3243-50. Epub 09/11/2014.\n\nCost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.\n\nStroupe KT, Weaver FM, Cao L, Ippolito D, Barton BR, Burnett-Zeigler IE, Holloway RG, Vickrey BG, Simuni T, Follett KA\n\nMovement disorders : official journal of the Movement Disorder Society.. 2014 November 29 (13):1666-74. Epub 09/15/2014.\n\nCurrent practices in feeding tube placement for US acute ischemic stroke inpatients.\n\nGeorge BP, Kelly AG, Schneider EB, Holloway RG\n\nNeurology.. 2014 September 283 (10):874-82. Epub 08/06/2014.\n\nEthical considerations in elective amputation after traumatic peripheral nerve injuries.\n\nSmith JK, Myers KP, Holloway RG, Landau ME\n\nNeurology. Clinical practice.. 2014 August 4 (4):280-286. Epub 1900 01 01.\n\nHemicraniectomy for middle-cerebral-artery stroke.\n\nKelly AG, Holloway RG\n\nThe New England journal of medicine.. 2014 June 12370 (24):2346-7. Epub 1900 01 01.\n\nPalliative and end-of-life care in stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association.\n\nHolloway RG, Arnold RM, Creutzfeldt CJ, Lewis EF, Lutz BJ, McCann RM, Rabinstein AA, Saposnik G, Sheth KN, Zahuranec DB, Zipfel GJ, Zorowitz RD,\n\nStroke.. 2014 June 45 (6):1887-916. Epub 03/27/2014.\n\nRisk adjustment of ischemic stroke outcomes for comparing hospital performance: a statement for healthcare professionals from the American Heart Association/American Stroke Association.\n\nKatzan IL, Spertus J, Bettger JP, Bravata DM, Reeves MJ, Smith EE, Bushnell C, Higashida RT, Hinchey JA, Holloway RG, Howard G, King RB, Krumholz HM, Lutz BJ, Yeh RW, , , , , ,\n\nStroke.. 2014 March 45 (3):918-44. Epub 01/23/2014.\n\nVariation in do-not-resuscitate orders for patients with ischemic stroke: implications for national hospital comparisons.\n\nKelly AG, Zahuranec DB, Holloway RG, Morgenstern LB, Burke JF\n\nStroke.. 2014 March 45 (3):822-7. Epub 02/12/2014.\n\nEthical considerations in stroke patients.\n\nKelly AG, Sahin B, Holloway RG\n\nCurrent opinion in neurology.. 2014 February 27 (1):61-5. Epub 1900 01 01.\n\nEvidence-based research ethics and determinations of &quot;engagement in research&quot;.\n\nWilson R, Kieburtz K, Holloway RG, Kim SY\n\nIRB.. 2014 36 (2):10-3. Epub 1900 01 01.\n\nReading a cost-effectiveness or decision analysis study: Five things to consider.\n\nYoung KC, Kelly AG, Holloway RG\n\nNeurology. Clinical practice.. 2013 October 3 (5):413-420. Epub 1900 01 01.\n\nThe evolving role and value of libraries and librarians in health care.\n\nSollenberger JF, Holloway RG\n\nJAMA.. 2013 September 25310 (12):1231-2. Epub 1900 01 01.\n\nEstimating and communicating prognosis in advanced neurologic disease.\n\nHolloway RG, Gramling R, Kelly AG\n\nNeurology.. 2013 February 1980 (8):764-72. Epub 1900 01 01.\n\nToo important to fail.\n\nBenesch CG, Holloway RG\n\nAnnals of neurology.. 2013 February 73 (2):153-4. Epub 1900 01 01.\n\nResearch participants' &quot;irrational&quot; expectations: common or commonly mismeasured?\n\nKim SY, de Vries R, Wilson R, Parnami S, Frank S, Kieburtz K, Holloway RG\n\nIRB.. 2013 35 (1):1-9. Epub 1900 01 01.\n\nTreatment decisions after severe stroke: uncertainty and biases.\n\nCreutzfeldt CJ, Holloway RG\n\nStroke.. 2012 December 43 (12):3405-8. Epub 11/13/2012.\n\nSham surgery controls in Parkinson's disease clinical trials: views of participants.\n\nKim SY, De Vries R, Holloway RG, Wilson R, Parnami S, Kim HM, Frank S, Kieburtz K\n\nMovement disorders : official journal of the Movement Disorder Society.. 2012 September 1527 (11):1461-5. Epub 08/23/2012.\n\nParkinson's disease medication use and costs following deep brain stimulation.\n\nWeaver FM, Stroupe KT, Cao L, Holloway RG, Vickrey BG, Simuni T, Hendricks A, Ippolito D\n\nMovement disorders : official journal of the Movement Disorder Society.. 2012 September 1527 (11):1398-403. Epub 09/13/2012.\n\nEarly stroke mortality, patient preferences, and the withdrawal of care bias.\n\nKelly AG, Hoskins KD, Holloway RG\n\nNeurology.. 2012 August 2879 (9):941-4. Epub 1900 01 01.\n\nSymptomatic and palliative care for stroke survivors.\n\nCreutzfeldt CJ, Holloway RG, Walker M\n\nJournal of general internal medicine.. 2012 July 27 (7):853-60. Epub 01/19/2012.\n\nChallenges in assessing hospital-level stroke mortality as a quality measure: comparison of ischemic, intracerebral hemorrhage, and total stroke mortality rates.\n\nXian Y, Holloway RG, Pan W, Peterson ED\n\nStroke.. 2012 June 43 (6):1687-90. Epub 04/24/2012.\n\nEvidence, preferences, recommendations--finding the right balance in patient care.\n\nQuill TE, Holloway RG\n\nThe New England journal of medicine.. 2012 May 3366 (18):1653-5. Epub 1900 01 01.\n\nComparison of enrollees and decliners of Parkinson disease sham surgery trials.\n\nKim SY, Wilson RM, Kim HM, Holloway RG, De Vries RG, Frank SA, Kieburtz K\n\nMovement disorders : official journal of the Movement Disorder Society.. 2012 April 27 (4):506-11. Epub 02/07/2012.\n\nIn lieu of flowers….\n\nHolloway RG\n\nJournal of palliative medicine.. 2011 December 14 (12):1348-9. Epub 1900 01 01.\n\nPalliative care needs and symptom patterns of hospitalized elders referred for consultation.\n\nOlden AM, Holloway R, Ladwig S, Quill TE, van Wijngaarden E\n\nJournal of pain and symptom management.. 2011 September 42 (3):410-8. Epub 03/27/2011.\n\nCost-effectiveness of disease-modifying therapy for multiple sclerosis: a population-based study.\n\nNoyes K, Bajorska A, Chappel A, Schwid SR, Mehta LR, Weinstock-Guttman B, Holloway RG, Dick AW\n\nNeurology.. 2011 July 2677 (4):355-63. Epub 07/20/2011.\n\nGetting to value in neurological care: a roadmap for academic neurology.\n\nHolloway RG, Ringel SP\n\nAnnals of neurology.. 2011 June 69 (6):909-18. Epub 1900 01 01.\n\nPearls &amp; Oy-sters: a stroke of luck: detecting type A aortic dissection by MRA.\n\nHyland MH, Holloway RG\n\nNeurology.. 2011 February 2276 (8):e31-3. Epub 1900 01 01.\n\nRacial differences in mortality among patients with acute ischemic stroke: an observational study.\n\nXian Y, Holloway RG, Noyes K, Shah MN, Friedman B\n\nAnnals of internal medicine.. 2011 February 1154 (3):152-9. Epub 1900 01 01.\n\nAssociation between stroke center hospitalization for acute ischemic stroke and mortality.\n\nXian Y, Holloway RG, Chan PS, Noyes K, Shah MN, Ting HH, Chappel AR, Peterson ED, Friedman B\n\nJAMA.. 2011 January 26305 (4):373-80. Epub 1900 01 01.\n\nAssociation between stroke center hospitalization for acute ischemic stroke and mortality\n\nXian,Y.; Holloway,R. G.; Chan,P. S.; Noyes,K.; Shah,M. N.; Ting,H. H.; Chappel,A. R.; Peterson,E. D.; Friedman,B.;.\n\nJAMA. 2011; 305(4): 373-380.\n\nRacial differences in mortality among patients with acute ischemic stroke: an observational study\n\nXian,Y.; Holloway,R. G.; Noyes,K.; Shah,M. N.; Friedman,B.;.\n\nAnn.Intern.Med. 2011; 154(3): 152-159.\n\nHealth state preferences and decision-making after malignant middle cerebral artery infarctions.\n\nKelly AG, Holloway RG\n\nNeurology.. 2010 August 2475 (8):682-7. Epub 07/14/2010.\n\nIs it research?: an increasingly common question.\n\nKim SY, Holloway RG\n\nNeurology.. 2010 July 1375 (2):102-4. Epub 1900 01 01.\n\nTreatment decisions after brain injury--tensions among quality, preference, and cost.\n\nHolloway RG, Quill TE\n\nThe New England journal of medicine.. 2010 May 13362 (19):1757-9. Epub 1900 01 01.\n\nPalliative care consultations in hospitalized stroke patients.\n\nHolloway RG, Ladwig S, Robb J, Kelly A, Nielsen E, Quill TE\n\nJournal of palliative medicine.. 2010 April 13 (4):407-12. Epub 1900 01 01.\n\nAre quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals.\n\nXian Y, Pan W, Peterson ED, Heidenreich PA, Cannon CP, Hernandez AF, Friedman B, Holloway RG, Fonarow GC,\n\nAmerican heart journal.. 2010 February 159 (2):207-14. Epub 1900 01 01.\n\nPalliative care consultations in hospitalized stroke patients\n\nHolloway,R. G.; Ladwig,S.; Robb,J.; Kelly,A.; Nielsen,E.; Quill,T. E.;.\n\nJ.Palliat.Med. 2010; 13(4): 407-412.\n\nTreatment decisions after brain injury--tensions among quality, preference, and cost\n\nHolloway,R. G.; Quill,T. E.;.\n\nN.Engl.J.Med. 2010; 362(19): 1757-1759.\n\nHealth state preferences and decision-making after malignant middle cerebral artery infarctions\n\nKelly,A. G.; Holloway,R. G.;.\n\nNeurology. 2010; 75(8): 682-687.\n\nIs it research?: an increasingly common question\n\nKim,S. Y.; Holloway,R. G.;.\n\nNeurology. 2010; 75(2): 102-104.\n\nTreatment of malignant pleural effusion: PleuRx catheter or talc pleurodesis? A cost-effectiveness analysis\n\nOlden,A. M.; Holloway,R.;.\n\nJ.Palliat.Med. 2010; 13(1): 59-65.\n\nAre quality improvements associated with the Get With the Guidelines-Coronary Artery Disease (GWTG-CAD) program sustained over time? A longitudinal comparison of GWTG-CAD hospitals versus non-GWTG-CAD hospitals\n\nXian,Y.; Pan,W.; Peterson,E. D.; Heidenreich,P. A.; Cannon,C. P.; Hernandez,A. F.; Friedman,B.; Holloway,R. G.; Fonarow,G. C.; GWTG Steering Committee and Hospitals;.\n\nAm.Heart J. 2010; 159(2): 207-214.\n\nA cost-effectiveness analysis of carotid artery stenting compared with endarterectomy\n\nYoung,K. C.; Holloway,R. G.; Burgin,W. S.; Benesch,C. G.;.\n\nJ.Stroke Cerebrovasc Dis. 2010; 19(5): 404-409.\n\nA cost-effectiveness analysis of carotid artery stenting compared with endarterectomy.\n\nYoung KC, Holloway RG, Burgin WS, Benesch CG\n\nJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.. 2010 19 (5):404-9. Epub 1900 01 01.\n\nPatient and organizational factors related to education and support use by Veterans with Parkinson's disease.\n\nPogoda TK, Cramer IE, Meterko M, Lin H, Hendricks A, Holloway RG, Charns MP\n\nMovement disorders : official journal of the Movement Disorder Society.. 2009 October 1524 (13):1916-24. Epub 1900 01 01.\n\nFinancing of U.S. biomedical research and new drug approvals across therapeutic areas.\n\nDorsey ER, Thompson JP, Carrasco M, de Roulet J, Vitticore P, Nicholson S, Johnston SC, Holloway RG, Moses H\n\nPloS one.. 2009 September 114 (9):e7015. Epub 09/11/2009.\n\nEffects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model.\n\nYurcheshen ME, Guttuso T, McDermott M, Holloway RG, Perlis M\n\nJournal of women's health.. 2009 September 18 (9):1355-60. Epub 1900 01 01.\n\nSelegiline shortage: Causes and costs of a generic drug shortage.\n\nDorsey ER, Thompson JP, Dayoub EJ, George B, Saubermann LA, Holloway RG\n\nNeurology.. 2009 July 2173 (3):213-7. Epub 1900 01 01.\n\nA review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association.\n\nSchwamm LH, Holloway RG, Amarenco P, Audebert HJ, Bakas T, Chumbler NR, Handschu R, Jauch EC, Knight WA, Levine SR, Mayberg M, Meyer BC, Meyers PM, Skalabrin E, Wechsler LR, ,\n\nStroke.. 2009 July 40 (7):2616-34. Epub 05/07/2009.\n\nFunding of Parkinson research from industry and US federal and foundation sources.\n\nDorsey ER, Thompson JP, Frasier M, Sherer T, Fiske B, Nicholson S, Johnston SC, Holloway RG, Moses H\n\nMovement disorders : official journal of the Movement Disorder Society.. 2009 April 1524 (5):731-7. Epub 1900 01 01.\n\nWhen disclosures are more interesting than the evidence.\n\nHolloway RG, Benesch C\n\nStroke.. 2009 February 40 (2):e44; author reply e45. Epub 12/18/2008.\n\nFinancing of U.S. biomedical research and new drug approvals across therapeutic areas\n\nDorsey,E. R.; Thompson,J. P.; Carrasco,M.; de Roulet,J.; Vitticore,P.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.\n\nPLoS One. 2009; 4(9): e7015.\n\nFunding of Parkinson research from industry and US federal and foundation sources\n\nDorsey,E. R.; Thompson,J. P.; Frasier,M.; Sherer,T.; Fiske,B.; Nicholson,S.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.\n\nMov.Disord. 2009; 24(5): 731-737.\n\nUtilization, diagnosis, treatment and cost of migraine treatment in the emergency department\n\nFriedman,D.; Feldon,S.; Holloway,R.; Fisher,S.;.\n\nHeadache. 2009; 49(8): 1163-1173.\n\nWhen disclosures are more interesting than the evidence\n\nHolloway,R. G.; Benesch,C.;.\n\nStroke. 2009; 40(2): e44; author reply e45.\n\nAn approach to evaluating the therapeutic misconception\n\nKim,S. Y.; Schrock,L.; Wilson,R. M.; Frank,S. A.; Holloway,R. G.; Kieburtz,K.; de Vries,R. G.;.\n\nIRB. 2009; 31(5): 7-14.\n\nPatient and organizational factors related to education and support use by Veterans with Parkinson's disease\n\nPogoda,T. K.; Cramer,I. E.; Meterko,M.; Lin,H.; Hendricks,A.; Holloway,R. G.; Charns,M. P.;.\n\nMov.Disord. 2009; 24(13): 1916-1924.\n\nA review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association\n\nSchwamm,L. H.; Holloway,R. G.; Amarenco,P.; Audebert,H. J.; Bakas,T.; Chumbler,N. R.; Handschu,R.; Jauch,E. C.; Knight,W. A.,4th; Levine,S. R.; Mayberg,M.; Meyer,B. C.; Meyers,P. M.; Skalabrin,E.; Wechsler,L. R.; American Heart Association Stroke Council; Interdisciplinary Council on Peripheral Vascular Disease;.\n\nStroke. 2009; 40(7): 2616-2634.\n\nEffects of gabapentin on sleep in menopausal women with hot flashes as measured by a Pittsburgh Sleep Quality Index factor scoring model\n\nYurcheshen,M. E.; Guttuso,T.,Jr; McDermott,M.; Holloway,R. G.; Perlis,M.;.\n\nJ.Womens Health.(Larchmt). 2009; 18(9): 1355-1360.\n\nAn approach to evaluating the therapeutic misconception.\n\nKim SY, Schrock L, Wilson RM, Frank SA, Holloway RG, Kieburtz K, de Vries RG\n\nIRB.. 2009 31 (5):7-14. Epub 1900 01 01.\n\nTrust in early phase research: therapeutic optimism and protective pessimism.\n\nKim SY, Holloway RG, Frank S, Wilson R, Kieburtz K\n\nMedicine, health care, and philosophy.. 2008 December 11 (4):393-401. Epub 07/16/2008.\n\nPublic reporting of quality data for stroke: is it measuring quality?\n\nKelly A, Thompson JP, Tuttle D, Benesch C, Holloway RG\n\nStroke.. 2008 December 39 (12):3367-71. Epub 09/04/2008.\n\nQuantitative risk-benefit analysis of natalizumab.\n\nThompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG\n\nNeurology.. 2008 July 2971 (5):357-64. Epub 1900 01 01.\n\nInvited Article: Conflicts of interest for authors of American Academy of Neurology clinical practice guidelines.\n\nHolloway RG, Mooney CJ, Getchius TS, Edlund WS, Miyasaki JO\n\nNeurology.. 2008 July 171 (1):57-63. Epub 1900 01 01.\n\nInvited article: Neurology and quality improvement: an introduction.\n\nBever CT, Holloway RG, Iverson DJ, Dubinsky RM, Richardson RM, Sheffield JK, Wang DZ, Franklin GM, Miyasaki JM, Tonn ST, Stevens JC\n\nNeurology.. 2008 April 2970 (18):1636-40. Epub 1900 01 01.\n\nEthics of sham surgery: perspective of patients.\n\nFrank SA, Wilson R, Holloway RG, Zimmerman C, Peterson DR, Kieburtz K, Kim SY\n\nMovement disorders : official journal of the Movement Disorder Society.. 2008 January 23 (1):63-8. Epub 1900 01 01.\n\nEthics of sham surgery: perspective of patients\n\nFrank,S. A.; Wilson,R.; Holloway,R. G.; Zimmerman,C.; Peterson,D. R.; Kieburtz,K.; Kim,S. Y.;.\n\nMov.Disord. 2008; 23(1): 63-68.\n\nMovement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results\n\nGoetz,C. G.; Tilley,B. C.; Shaftman,S. R.; Stebbins,G. T.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stern,M. B.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; van Hilten,J. J.; LaPelle,N.; Movement Disorder Society UPDRS Revision Task Force;.\n\nMov.Disord. 2008; 23(15): 2129-2170.\n\nPublic reporting of quality data for stroke: is it measuring quality?\n\nKelly,A.; Thompson,J. P.; Tuttle,D.; Benesch,C.; Holloway,R. G.;.\n\nStroke. 2008; 39(12): 3367-3371.\n\nTrust in early phase research: therapeutic optimism and protective pessimism\n\nKim,S. Y.; Holloway,R. G.; Frank,S.; Wilson,R.; Kieburtz,K.;.\n\nMed.Health Care Philos. 2008; 11(4): 393-401.\n\nA cost-utility comparison of four first-line medications in painful diabetic neuropathy\n\nO'Connor,A. B.; Noyes,K.; Holloway,R. G.;.\n\nPharmacoeconomics. 2008; 26(12): 1045-1064.\n\nA cost-utility comparison of four first-line medications in painful diabetic neuropathy.\n\nO'Connor AB, Noyes K, Holloway RG\n\nPharmacoEconomics.. 2008 26 (12):1045-64. Epub 1900 01 01.\n\nQuality of life in epilepsy, multiple sclerosis, and beyond.\n\nDorsey ER, Holloway RG\n\nAnnals of neurology.. 2007 October 62 (4):307-8. Epub 1900 01 01.\n\nMortality as a measure of quality: implications for palliative and end-of-life care.\n\nHolloway RG, Quill TE\n\nJAMA.. 2007 August 15298 (7):802-4. Epub 1900 01 01.\n\nA cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia.\n\nO'Connor AB, Noyes K, Holloway RG\n\nJournal of the American Geriatrics Society.. 2007 August 55 (8):1176-84. Epub 1900 01 01.\n\nRisk factors for somnolence, edema, and hallucinations in early Parkinson disease.\n\nBiglan KM, Holloway RG, McDermott MP, Richard IH,\n\nNeurology.. 2007 July 1069 (2):187-95. Epub 1900 01 01.\n\nProactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients.\n\nNorton SA, Hogan LA, Holloway RG, Temkin-Greener H, Buckley MJ, Quill TE\n\nCritical care medicine.. 2007 June 35 (6):1530-5. Epub 1900 01 01.\n\nQuantifying the risks and benefits of natalizumab in relapsing multiple sclerosis.\n\nDorsey ER, Thompson JP, Noyes K, Dick AW, Holloway RG, Schwid SR\n\nNeurology.. 2007 May 168 (18):1524-8. Epub 1900 01 01.\n\nHealth care costs decline after successful epilepsy surgery.\n\nLangfitt JT, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Spencer SS, Vickrey BG, Sperling MR, Bazil CW, Shinnar S\n\nNeurology.. 2007 April 1768 (16):1290-8. Epub 1900 01 01.\n\nAccuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey.\n\nNoyes K, Liu H, Holloway R, Dick AW\n\nMovement disorders : official journal of the Movement Disorder Society.. 2007 March 1522 (4):509-14. Epub 1900 01 01.\n\nMedical errors after stroke: preventable or inevitable?\n\nRizzo M, Glick TH\n\nNeurology.. 2007 February 2068 (8):542-3. Epub 1900 01 01.\n\nThe safety of hospital stroke care.\n\nHolloway RG, Tuttle D, Baird T, Skelton WK\n\nNeurology.. 2007 February 2068 (8):550-5. Epub 1900 01 01.\n\nProjected number of people with Parkinson disease in the most populous nations, 2005 through 2030.\n\nDorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM\n\nNeurology.. 2007 January 3068 (5):384-6. Epub 11/02/2006.\n\nDiffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?\n\nLittle DM, Holloway RG\n\nNeurology.. 2007 January 268 (1):9-10. Epub 1900 01 01.\n\nMovement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.\n\nGoetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N\n\nMovement disorders : official journal of the Movement Disorder Society.. 2007 January 22 (1):41-7. Epub 1900 01 01.\n\nRisk factors for somnolence, edema, and hallucinations in early Parkinson disease\n\nBiglan,K. M.; Holloway,R. G.,Jr; McDermott,M. P.; Richard,I. H.; Parkinson Study Group CALM-PD Investigators;.\n\nNeurology. 2007; 69(2): 187-195.\n\nQuality of life in epilepsy, multiple sclerosis, and beyond\n\nDorsey,E. R.; Holloway,R. G.;.\n\nAnn.Neurol. 2007; 62(4): 307-308.\n\nMovement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan\n\nGoetz,C. G.; Fahn,S.; Martinez-Martin,P.; Poewe,W.; Sampaio,C.; Stebbins,G. T.; Stern,M. B.; Tilley,B. C.; Dodel,R.; Dubois,B.; Holloway,R.; Jankovic,J.; Kulisevsky,J.; Lang,A. E.; Lees,A.; Leurgans,S.; LeWitt,P. A.; Nyenhuis,D.; Olanow,C. W.; Rascol,O.; Schrag,A.; Teresi,J. A.; Van Hilten,J. J.; LaPelle,N.;.\n\nMov.Disord. 2007; 22(1): 41-47.\n\nMortality as a measure of quality: implications for palliative and end-of-life care\n\nHolloway,R. G.; Quill,T. E.;.\n\nJAMA. 2007; 298(7): 802-804.\n\nThe safety of hospital stroke care\n\nHolloway,R. G.; Tuttle,D.; Baird,T.; Skelton,W. K.;.\n\nNeurology. 2007; 68(8): 550-555.\n\nDiffusion tensor imaging: scientific advance, clinical tool, or just a pretty picture?\n\nLittle,D. M.; Holloway,R. G.;.\n\nNeurology. 2007; 68(1): 9-10.\n\nProactive palliative care in the medical intensive care unit: effects on length of stay for selected high-risk patients\n\nNorton,S. A.; Hogan,L. A.; Holloway,R. G.; Temkin-Greener,H.; Buckley,M. J.; Quill,T. E.;.\n\nCrit.Care Med. 2007; 35(6): 1530-1535.\n\nThe implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation\n\nNoyes,K.; Dick,A. W.; Holloway,R. G.;.\n\nMed.Decis.Making. 2007; 27(3): 327-334.\n\nAccuracy of Medicare claims data in identifying Parkinsonism cases: comparison with the Medicare current beneficiary survey\n\nNoyes,K.; Liu,H.; Holloway,R.; Dick,A. W.;.\n\nMov.Disord. 2007; 22(4): 509-514.\n\nA cost-effectiveness comparison of desipramine, gabapentin, and pregabalin for treating postherpetic neuralgia\n\nO'Connor,A. B.; Noyes,K.; Holloway,R. G.;.\n\nJ.Am.Geriatr.Soc. 2007; 55(8): 1176-1184.\n\nThe implications of using US-specific EQ-5D preference weights for cost-effectiveness evaluation.\n\nNoyes K, Dick AW, Holloway RG\n\nMedical decision making : an international journal of the Society for Medical Decision Making.. 2007 27 (3):327-34. Epub 05/14/2007.\n\nFinancial anatomy of neuroscience research.\n\nDorsey ER, Vitticore P, De Roulet J, Thompson JP, Carrasco M, Johnston SC, Holloway RG, Moses H\n\nAnnals of neurology.. 2006 December 60 (6):652-9. Epub 1900 01 01.\n\nThere is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies.\n\nJohnston KC, Holloway RG\n\nNeurology.. 2006 September 1267 (5):740-1. Epub 1900 01 01.\n\nBiomarkers in Parkinson's disease.\n\nDorsey ER, Holloway RG, Ravina BM\n\nExpert review of neurotherapeutics.. 2006 June 6 (6):823-31. Epub 1900 01 01.\n\nVolunteering for early phase gene transfer research in Parkinson disease.\n\nKim SY, Holloway RG, Frank S, Beck CA, Zimmerman C, Wilson R, Kieburtz K\n\nNeurology.. 2006 April 1166 (7):1010-5. Epub 03/15/2006.\n\nWhat is the risk of developing parkinsonism following neuroleptic use?\n\nNoyes K, Liu H, Holloway RG\n\nNeurology.. 2006 March 2866 (6):941-3. Epub 1900 01 01.\n\nUpdate in neurology.\n\nHolloway RG, Józefowicz RF\n\nAnnals of internal medicine.. 2006 March 21144 (6):421-6. Epub 1900 01 01.\n\nEconomic burden associated with Parkinson's disease on elderly Medicare beneficiaries.\n\nNoyes K, Liu H, Li Y, Holloway R, Dick AW\n\nMovement disorders : official journal of the Movement Disorder Society.. 2006 March 21 (3):362-72. Epub 1900 01 01.\n\nBiomarkers in Parkinson's disease\n\nDorsey,E. R.; Holloway,R. G.; Ravina,B. M.;.\n\nExpert Rev.Neurother. 2006; 6(6): 823-831.\n\nFinancial anatomy of neuroscience research\n\nDorsey,E. R.; Vitticore,P.; De Roulet,J.; Thompson,J. P.; Carrasco,M.; Johnston,S. C.; Holloway,R. G.; Moses,H.,3rd;.\n\nAnn.Neurol. 2006; 60(6): 652-659.\n\nReview: lorazepam provides the best control for status epilepticus\n\nHenry,J. C.; Holloway,R.;.\n\nEvid Based.Med. 2006; 11(2): 54.\n\nReview: Lorazepam provides the best control for status epilepticus\n\nHenry,J. C.; Holloway,R.;.\n\nACP J.Club. 2006; 144(2): 35.\n\nUpdate in neurology\n\nHolloway,R. G.,Jr; Jozefowicz,R. F.;.\n\nAnn.Intern.Med. 2006; 144(6): 421-426.\n\nThere is nothing staid about STARD: progress in the reporting of diagnostic accuracy studies\n\nJohnston,K. C.; Holloway,R. G.;.\n\nNeurology. 2006; 67(5): 740-741.\n\nReview: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients\n\nKelly,A. G.; Holloway,R. G.;.\n\nACP J.Club. 2006; 145(3): 77.\n\nPramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life\n\nNoyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;.\n\nValue Health. 2006; 9(1): 28-38.\n\nWhat is the risk of developing parkinsonism following neuroleptic use?\n\nNoyes,K.; Liu,H.; Holloway,R. G.;.\n\nNeurology. 2006; 66(6): 941-943.\n\nEconomic burden associated with Parkinson's disease on elderly Medicare beneficiaries\n\nNoyes,K.; Liu,H.; Li,Y.; Holloway,R.; Dick,A. W.;.\n\nMov.Disord. 2006; 21(3): 362-372.\n\nPramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life.\n\nNoyes K, Dick AW, Holloway RG,\n\nValue in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.. 2006 9 (1):28-38. Epub 1900 01 01.\n\nReview: noninvasive imaging techniques may be useful for diagnosing 70% to 99% carotid stenosis in symptomatic patients.\n\nKelly AG, Holloway RG\n\nACP journal club.. 2006 145 (3):77. Epub 1900 01 01.\n\nWhat is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.\n\nFrank S, Kieburtz K, Holloway R, Kim SY\n\nNeurology.. 2005 October 1165 (7):1101-3. Epub 07/20/2005.\n\nCarotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.\n\nChaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J,\n\nNeurology.. 2005 September 2765 (6):794-801. Epub 1900 01 01.\n\nScience and ethics of sham surgery: a survey of Parkinson disease clinical researchers.\n\nKim SY, Frank S, Holloway R, Zimmerman C, Wilson R, Kieburtz K\n\nArchives of neurology.. 2005 September 62 (9):1357-60. Epub 1900 01 01.\n\nPrognosis and decision making in severe stroke.\n\nHolloway RG, Benesch CG, Burgin WS, Zentner JB\n\nJAMA.. 2005 August 10294 (6):725-33. Epub 1900 01 01.\n\nHow much is a good night's sleep worth?\n\nWilliams LS, Holloway RG\n\nStroke.. 2005 June 36 (6):1293-4. Epub 1900 01 01.\n\nResponsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report.\n\nGuttuso T, Vitticore P, Holloway RG\n\nJournal of neurosurgery.. 2005 March 102 (3):547-9. Epub 1900 01 01.\n\nThe Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care.\n\nLindsay MP, Kapral MK, Gladstone D, Holloway R, Tu JV, Laupacis A, Grimshaw JM\n\nCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.. 2005 February 1172 (3):363-5. Epub 1900 01 01.\n\nThe role of radiotracer imaging in Parkinson disease.\n\nRavina B, Eidelberg D, Ahlskog JE, Albin RL, Brooks DJ, Carbon M, Dhawan V, Feigin A, Fahn S, Guttman M, Gwinn-Hardy K, McFarland H, Innis R, Katz RG, Kieburtz K, Kish SJ, Lange N, Langston JW, Marek K, Morin L, Moy C, Murphy D, Oertel WH, Oliver G, Palesch Y, Powers W, Seibyl J, Sethi KD, Shults CW, Sheehy P, Stoessl AJ, Holloway R\n\nNeurology.. 2005 January 2564 (2):208-15. Epub 1900 01 01.\n\nEfficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.\n\nHolloway RG\n\nNeurology.. 2005 January 1164 (1):172-4; author reply 172-4. Epub 1900 01 01.\n\nWhat is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports\n\nFrank,S.; Kieburtz,K.; Holloway,R.; Kim,S. Y.;.\n\nNeurology. 2005; 65(7): 1101-1103.\n\nResponsiveness of life-threatening refractory emesis to gabapentin-scopolamine therapy following posterior fossa surgery. Case report\n\nGuttuso,T.,Jr; Vitticore,P.; Holloway,R. G.;.\n\nJ.Neurosurg. 2005; 102(3): 547-549.\n\nThe Babinski sign: thumbs up or toes down?\n\nHolloway,R.;.\n\nNeurology. 2005; 65(8): 1147.\n\nTiming and route of enteral tube-feeding did not reduce death or poor outcome in stroke and dysphagia\n\nHolloway,R.;.\n\nACP J.Club. 2005; 143(2): 37.\n\nProtein-energy supplementation of normal hospital diet did not improve outcomes after recent stroke\n\nHolloway,R.;.\n\nACP J.Club. 2005; 143(2): 36.\n\nEfficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society\n\nHolloway,R. G.;.\n\nNeurology. 2005; 64(1): 172-4; author reply 172-4.\n\nPrognosis and decision making in severe stroke\n\nHolloway,R. G.; Benesch,C. G.; Burgin,W. S.; Zentner,J. B.;.\n\nJAMA. 2005; 294(6): 725-733.\n\nScience and ethics of sham surgery: a survey of Parkinson disease clinical researchers\n\nKim,S. Y.; Frank,S.; Holloway,R.; Zimmerman,C.; Wilson,R.; Kieburtz,K.;.\n\nArch.Neurol. 2005; 62(9): 1357-1360.\n\nThe Canadian Stroke Quality of Care Study: establishing indicators for optimal acute stroke care\n\nLindsay,M. P.; Kapral,M. K.; Gladstone,D.; Holloway,R.; Tu,J. V.; Laupacis,A.; Grimshaw,J. M.;.\n\nCMAJ. 2005; 172(3): 363-365.\n\nPramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness\n\nNoyes,K.; Dick,A. W.; Holloway,R. G.; Parkinson Study Group;.\n\nPharmacoeconomics. 2005; 23(12): 1257-1270.\n\nHow much is a good night's sleep worth?\n\nWilliams,L. S.; Holloway,R. G.;.\n\nStroke. 2005; 36(6): 1293-1294.\n\nPramipexole and levodopa in early Parkinson's disease: dynamic changes in cost effectiveness.\n\nNoyes K, Dick AW, Holloway RG,\n\nPharmacoEconomics.. 2005 23 (12):1257-70. Epub 1900 01 01.\n\nMovement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.\n\nGoetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, Giladi N, Holloway RG, Moore CG, Wenning GK, Yahr MD, Seidl L,\n\nMovement disorders : official journal of the Movement Disorder Society.. 2004 September 19 (9):1020-8. Epub 1900 01 01.\n\nRandomized pilot trial of high-dose betaINF-1a in patients with inclusion body myositis.\n\nNeurology.. 2004 August 2463 (4):718-20. Epub 1900 01 01.\n\nTeaching and evaluating first and second year medical students' practice of evidence-based medicine.\n\nHolloway R, Nesbit K, Bordley D, Noyes K\n\nMedical education.. 2004 August 38 (8):868-78. Epub 1900 01 01.\n\nElectronic reporting to improve patient safety.\n\nTuttle D, Holloway R, Baird T, Sheehan B, Skelton WK\n\nQuality & safety in health care.. 2004 August 13 (4):281-6. Epub 1900 01 01.\n\nPramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.\n\nHolloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A,\n\nArchives of neurology.. 2004 July 61 (7):1044-53. Epub 1900 01 01.\n\nEvidence-based neurotherapeutics: a spectrum of evidence.\n\nHolloway RG, Siderowf AD\n\nNeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.. 2004 July 1 (3):295-7. Epub 1900 01 01.\n\nEvidence from cost-effectiveness research.\n\nNoyes K, Holloway RG\n\nNeuroRx : the journal of the American Society for Experimental NeuroTherapeutics.. 2004 July 1 (3):348-55. Epub 1900 01 01.\n\nMovement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations\n\nGoetz,C. G.; Poewe,W.; Rascol,O.; Sampaio,C.; Stebbins,G. T.; Counsell,C.; Giladi,N.; Holloway,R. G.; Moore,C. G.; Wenning,G. K.; Yahr,M. D.; Seidl,L.; Movement Disorder Society Task Force on Rating Scales for Parkinson's Disease;.\n\nMov.Disord. 2004; 19(9): 1020-1028.\n\nEditorial comment--stroke cost-effectiveness research: are acceptability curves acceptable?\n\nHolloway,R.; Dick,A. W.;.\n\nStroke. 2004; 35(1): 203-204.\n\nReview: anticholinergic drugs improve motor function and disability in Parkinson disease\n\nHolloway,R.; Frank,S.;.\n\nACP J.Club. 2004; 140(1): 15.\n\nEvidence-based neurotherapeutics: a spectrum of evidence\n\nHolloway,R. G.; Siderowf,A. D.;.\n\nNeuroRx. 2004; 1(3): 295-297.\n\nEvidence from cost-effectiveness research\n\nNoyes,K.; Holloway,R. G.;.\n\nNeuroRx. 2004; 1(3): 348-355.\n\nMedical errors on an inpatient neurology service.\n\nFrank S, Holloway R\n\nNeurology.. 2003 July 2261 (2):254-7. Epub 1900 01 01.\n\nSurrogate endpoints in Parkinson's disease research.\n\nBiglan KM, Holloway RG\n\nCurrent neurology and neuroscience reports.. 2003 July 3 (4):314-20. Epub 1900 01 01.\n\nDevelopment and testing of the Parkinson's disease quality of life scale.\n\nWelsh M, McDermott MP, Holloway RG, Plumb S, Pfeiffer R, Hubble J,\n\nMovement disorders : official journal of the Movement Disorder Society.. 2003 June 18 (6):637-45. Epub 1900 01 01.\n\nA Bayesian argument against rigid cut-offs in electrodiagnosis of median neuropathy at the wrist.\n\nNodera H, Herrmann DN, Holloway RG, Logigian EL\n\nNeurology.. 2003 February 1160 (3):458-64. Epub 1900 01 01.\n\nSurrogate endpoints in Parkinson's disease research\n\nBiglan,K. M.; Holloway,R. G.;.\n\nCurr.Neurol.Neurosci.Rep. 2003; 3(4): 314-320.\n\nMedical errors on an inpatient neurology service\n\nFrank,S.; Holloway,R.;.\n\nNeurology. 2003; 61(2): 254-257.\n\nBurdens and benefits of placebos in antidepressant clinical trials: a decision and cost-effectiveness analysis\n\nKim,S. Y.; Holloway,R. G.;.\n\nAm.J.Psychiatry. 2003; 160(7): 1272-1276.\n\nDevelopment and testing of the Parkinson's disease quality of life scale\n\nWelsh,M.; McDermott,M. P.; Holloway,R. G.; Plumb,S.; Pfeiffer,R.; Hubble,J.; Parkinson Study Group;.\n\nMov.Disord. 2003; 18(6): 637-645.\n\nCT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes.\n\nGottlieb RH, La TC, Erturk EN, Sotack JL, Voci SL, Holloway RG, Syed L, Mikityansky I, Tirkes AT, Elmarzouky R, Zwemer FL, Joseph JV, Davis D, DiGrazio WJ, Messing EM\n\nRadiology.. 2002 November 225 (2):441-9. Epub 1900 01 01.\n\nDopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression.\n\nJAMA.. 2002 April 3287 (13):1653-61. Epub 1900 01 01.\n\nClinical trial end points: on the road to nowhere?\n\nHolloway RG, Dick AW\n\nNeurology.. 2002 March 1258 (5):679-86. Epub 1900 01 01.\n\nA review of pramipexole and its clinical utility in Parkinson's disease.\n\nBiglan KM, Holloway RG\n\nExpert opinion on pharmacotherapy.. 2002 February 3 (2):197-210. Epub 1900 01 01.\n\nA review of pramipexole and its clinical utility in Parkinson's disease\n\nBiglan,K. M.; Holloway,R. G.;.\n\nExpert Opin.Pharmacother. 2002; 3(2): 197-210.\n\nCT in detecting urinary tract calculi: influence on patient imaging and clinical outcomes\n\nGottlieb,R. H.; La,T. C.; Erturk,E. N.; Sotack,J. L.; Voci,S. L.; Holloway,R. G.; Syed,L.; Mikityansky,I.; Tirkes,A. T.; Elmarzouky,R.; Zwemer,F. L.; Joseph,J. V.; Davis,D.; DiGrazio,W. J.; Messing,E. M.;.\n\nRadiology. 2002; 225(2): 441-449.\n\nClinical trial end points: on the road to nowhere?\n\nHolloway,R. G.; Dick,A. W.;.\n\nNeurology. 2002; 58(5): 679-686.\n\nRandomized pilot trial of betaINF1a (Avonex) in patients with inclusion body myositis.\n\nNeurology.. 2001 November 1357 (9):1566-70. Epub 1900 01 01.\n\nRandomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy.\n\nKissel JT, McDermott MP, Mendell JR, King WM, Pandya S, Griggs RC, Tawil R,\n\nNeurology.. 2001 October 2357 (8):1434-40. Epub 1900 01 01.\n\nDevelopment of performance measures for acute ischemic stroke.\n\nHolloway RG, Vickrey BG, Benesch C, Hinchey JA, Bieber J,\n\nStroke.. 2001 September 32 (9):2058-74. Epub 1900 01 01.\n\nDeep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis.\n\nTomaszewski KJ, Holloway RG\n\nNeurology.. 2001 August 2857 (4):663-71. Epub 1900 01 01.\n\nInitial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.\n\nBiglan K, Holloway RG\n\nCurrent neurology and neuroscience reports.. 2001 July 1 (4):329-36. Epub 1900 01 01.\n\nNeurologists' use of ICD-9CM codes for dementia.\n\nPippenger M, Holloway RG, Vickrey BG\n\nNeurology.. 2001 May 856 (9):1206-9. Epub 1900 01 01.\n\nLawyers, litigation, and liability: can they make patients safer?\n\nHolloway RG, Panzer RJ\n\nNeurology.. 2001 April 2456 (8):991-3. Epub 1900 01 01.\n\nUS neurologists: attitudes on rationing.\n\nHolloway RG, Ringel SP, Bernat JL, Keran CM, Lawyer BL\n\nNeurology.. 2000 November 2855 (10):1492-7. Epub 1900 01 01.\n\nA multicenter assessment of dopamine transporter imaging with DOPASCAN/SPECT in parkinsonism. Parkinson Study Group.\n\nNeurology.. 2000 November 2855 (10):1540-7. Epub 1900 01 01.\n\nPramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.\n\nJAMA.. 2000 October 18284 (15):1931-8. Epub 1900 01 01.\n\nSystematic review of clinical prediction rules for neuroimaging in the evaluation of dementia.\n\nGifford DR, Holloway RG, Vickrey BG\n\nArchives of internal medicine.. 2000 October 9160 (18):2855-62. Epub 1900 01 01.\n\nStroke prevention: narrowing the evidence-practice gap.\n\nHolloway RG, Benesch C, Rush SR\n\nNeurology.. 2000 May 2354 (10):1899-906. Epub 1900 01 01.\n\nCost-effectiveness analysis in Parkinson's disease: determining the value of interventions.\n\nSiderowf AD, Holloway RG, Stern MB\n\nMovement disorders : official journal of the Movement Disorder Society.. 2000 May 15 (3):439-45. Epub 1900 01 01.\n\nWeighing the evidence on DWI: caveat emptor.\n\nZivin JA, Holloway RG\n\nNeurology.. 2000 April 2554 (8):1552. Epub 1900 01 01.\n\nEmployment-seeking experiences of residents in 1996: a window into the neurology marketplace.\n\nLarson WL, Holloway RG, Keran CM\n\nNeurology.. 2000 January 1154 (1):214-8. Epub 1900 01 01.\n\nA randomized controlled trial comparing pramipexole with levodopa in early Parkinson's disease: design and methods of the CALM-PD Study. Parkinson Study Group.\n\nClinical neuropharmacology.. 2000 23 (1):34-44. Epub 1900 01 01.\n\nResolution of transient ischemic attacks and aortic arch thrombi on anticoagulant therapy.\n\nHolloway RG, Kantrowitz JT, St James EC, Giang D, Schwarz K\n\nEuropean neurology.. 2000 43 (3):184-5. Epub 1900 01 01.\n\nTo test or not to test? That is the question.\n\nHolloway RG, Feasby TE\n\nNeurology.. 1999 December 1053 (9):1905-7. Epub 1900 01 01.\n\nSystematic review of cost-effectiveness research of stroke evaluation and treatment.\n\nEbrahim S, Holloway RG, Benesch CG\n\nStroke.. 1999 December 30 (12):2759-68. Epub 1900 01 01.\n\nNeurological outcomes in late HIV infection: adverse impact of neurological impairment on survival and protective effect of antiviral therapy. AIDS Clinical Trial Group and Neurological AIDS Research Consortium study team.\n\nPrice RW, Yiannoutsos CT, Clifford DB, Zaborski L, Tselis A, Sidtis JJ, Cohen B, Hall CD, Erice A, Henry K\n\nAIDS.. 1999 September 1013 (13):1677-85. Epub 1900 01 01.\n\nImproving adherence to dementia guidelines through education and opinion leaders. A randomized, controlled trial.\n\nGifford DR, Holloway RG, Frankel MR, Albright CL, Meyerson R, Griggs RC, Vickrey BG\n\nAnnals of internal medicine.. 1999 August 17131 (4):237-46. Epub 1900 01 01.\n\nA randomized trial to implement practice recommendations: design and methods of the Dementia Care Study.\n\nHolloway RG, Gifford DR, Frankel MR, Vickrey BG\n\nControlled clinical trials. 1999 August 20 (4):369-85. Epub 1900 01 01.\n\nA systematic review of cost-effectiveness research of stroke evaluation and treatment.\n\nHolloway RG, Benesch CG, Rahilly CR, Courtright CE\n\nStroke.. 1999 July 30 (7):1340-9. Epub 1900 01 01.\n\nUS neurologists in the 1990's: trends in practice characteristics.\n\nHolloway RG, Vickrey BG, Keran CM, Lesser E, Iverson D, Larson W, Swarztrauber K\n\nNeurology.. 1999 April 2252 (7):1353-61. Epub 1900 01 01.\n\nCerebrovascular disease in patients with HIV-1 associated pulmonary hypertension.\n\nSchifitto G, Holloway R\n\nJournal of neuro-AIDS.. 1999 2 (2):57-64. Epub 1900 01 01.\n\nCost effectiveness of pramipexole in Parkinson's disease in the US.\n\nHoerger TJ, Bala MV, Rowland C, Greer M, Chrischilles EA, Holloway RG\n\nPharmacoEconomics.. 1998 November 14 (5):541-57. Epub 1900 01 01.\n\nMagnetic resonance imaging in delayed brachial plexopathy following a clavicular fracture.\n\nHolloway RG, Courtright CE, Rahilly CR, Totterman SM, Shrier D\n\nEuropean neurology.. 1998 August 40 (2):105-6. Epub 1900 01 01.\n\nNarrowing the evidence-practice gap. Strengthening the link between research and clinical practice.\n\nHolloway RG, Ringel SP\n\nNeurology.. 1998 February 50 (2):319-21. Epub 1900 01 01.\n\nCarotid endarterectomy trends in the patterns and outcomes of care at academic medical centers, 1990 through 1995.\n\nHolloway RG, Witter DM, Mushlin AI, Lawton KB, McDermott MP, Samsa GP\n\nArchives of neurology.. 1998 January 55 (1):25-32. Epub 1900 01 01.\n\nEconomic impact of stoke and implications for interventions\n\nBenesch,C.; Holloway RG;.\n\nCNS Drugs. 1998; 9(1): 29-39.\n\nReversible symptomatic venous congestion after treatment of dural arteriovenous fistula using NBCA.\n\nUchino A, Numaguchi Y, Holloway RG, Cherian N\n\nRadiation medicine.. 1998 16 (6):477-81. Epub 1900 01 01.\n\nThe cost-effectiveness of magnetic resonance imaging for patients with equivocal neurological symptoms.\n\nMushlin AI, Mooney C, Holloway RG, Detsky AS, Mattson DH, Phelps CE\n\nInternational journal of technology assessment in health care.. 1997 13 (1):21-34. Epub 1900 01 01.\n\nCost-effectiveness analysis: what is it and how will it influence neurology.\n\nHolloway RG\n\nAnnals of neurology.. 1996 June 39 (6):818-23. Epub 1900 01 01.\n\nIntracranial mass lesions in acquired immunodeficiency syndrome: using decision analysis to determine the effectiveness of stereotactic brain biopsy.\n\nHolloway RG, Mushlin AI\n\nNeurology.. 1996 April 46 (4):1010-5. Epub 1900 01 01.\n\nInpatient costs of specific cerebrovascular events at five academic medical centers.\n\nHolloway RG, Witter DM, Lawton KB, Lipscomb J, Samsa G\n\nNeurology.. 1996 March 46 (3):854-60. Epub 1900 01 01.\n\nCognitive performance and regional brain volume in human immunodeficiency virus type 1 infection.\n\nKieburtz K, Ketonen L, Cox C, Grossman H, Holloway R, Booth H, Hickey C, Feigin A, Caine ED\n\nArchives of neurology.. 1996 February 53 (2):155-8. Epub 1900 01 01.\n\nHeadache and the human immunodeficiency virus type 1 infection.\n\nHolloway RG, Kieburtz KD\n\nHeadache.. 1995 May 35 (5):245-55. Epub 1900 01 01.\n\nStructure of the gene for cartilage matrix protein, a modular protein of the extracellular matrix. Exon/intron organization, unusual splice sites, and relation to alpha chains of beta 2 integrins, von Willebrand factor, complement factors B and C2, and epidermal growth factor.\n\nKiss I, Deák F, Holloway RG, Delius H, Mebust KA, Frimberger E, Argraves WS, Tsonis PA, Winterbottom N, Goetinck PF\n\nThe Journal of biological chemistry.. 1989 May 15264 (14):8126-34. Epub 1900 01 01.\n\nManagement can reverse declining employee work attitudeoblem solving.\n\nHolloway RG\n\nHospitals.. 1976 October 1650 (20):71-77. Epub 1900 01 01.\n\nPlanning for results and specific outcomes.\n\nHolloway RG\n\nHospitals.. 1976 May 1650 (10):77-8, 80, 82. Epub 1900 01 01.\n\nThe administrator and the future of collective actions.\n\nHolloway RG\n\nA report of the ... National Forum on Hospital and Health Affairs. 1976 :70-83. Epub 1900 01 01.\n\nWork-study career mobility program.\n\nHolloway S, Holloway RG\n\nHospitals.. 1972 August 1646 (16):73-6. Epub 1900 01 01.\n\nA survey program for management and organizational development.\n\nHolloway RG, Lonergan WG\n\nHospitals.. 1968 August 1642 (16):59-65. Epub 1900 01 01.\n\nThe participation patterns of &quot;economic influentials&quot; and their control of a hospital board of trusties.\n\nHOLLOWAY RG, ARTIS JW, FREEMAN WE\n\nJournal of health and human behavior.. 1963 4 :88-99. Epub 1900 01 01.\n\nReduction in Health Care Costs After Successful Epilepsy Surgery: Results of a US Multi-center Study.\n\nLangfitt JL, Holloway RG, McDermott MP, Messing S, Sarosky K, Berg AT, Vickrey, BG, Sperling MR, Spencer SS, Bazil CW, and Shinnar S.\n\nNeurology. .\n\nUse of US-Specific EQ-5D Preference Weights: The Implications for the Cost-Effectiveness of Pramipexole.\n\nNoyes K, Dick AW, Holloway RG and the Parkinson Study Group.\n\nMedical Decision Making.\n\nRisk Factors for Somnolence, Edema and Hallucinations in Early Parkinson's Disease.\n\nBiglan KM, Holloway RG, McDermott MP, Richard IR and the Parkinson Study Group CALM-PD Investigators.\n\nNeurology. .\n\nProactive Palliative Care in the Medical Intensive Care Unit: Reducing Length of Stay.\n\nNorton SA, Hogan L, Holloway R, Temkin Greener H, Buckley M, and Quill TE.\n\nCritical Care Medicine. .\n\nA cost-effectiveness comparison of desirpramine, gabapentin, and pregabalin for treating postherpetic neuralgia.\n\nO'Connor AB, K Noyes, Holloway RG.\n\nJAGS. .\n\nA Clinical Decision Model of Two Disease Modifying Agents for Multiple Sclerosis.\n\nThompson JP, Noyes K, Dorsey ER, Schwid SR, Holloway RG.\n\nIntl. J. of Technology Assessment in Health Care."
    }
}